DESIGN, FORMULATION, AND EVALUATION OF SOLID DISPERSION TABLETS OF POORLY WATER-SOLUBLE ANTIDIABETIC DRUG USING NATURAL POLYMER by SUDIPTA DAS & PRIYANKA MANDAL
Vol 12, Issue 4, 2019
Online - 2455-3891 
Print - 0974-2441
DESIGN, FORMULATION, AND EVALUATION OF SOLID DISPERSION TABLETS OF POORLY 
WATER-SOLUBLE ANTIDIABETIC DRUG USING NATURAL POLYMER
SUDIPTA DAS*, PRIYANKA MANDAL
Department of Pharmaceutics, Netaji Subhas Chandra Bose Institute of Pharmacy, Chakdaha, Nadia, West Bengal, India. 
Email: sudiptapharmacy6@gmail.com
Received: 26 January 2019, Revised and Accepted: 5 March 2019
ABSTRACT
Objective: The objective of the present study was to formulate the solid dispersion (SD) of poorly water-soluble drug glimepiride and the development 
of the tablets of prepared SD of glimepiride using natural and synthetic polymers.
Methods: The SD of glimepiride was to prepare using fusion method. The tablets were prepared by wet granulation method using synthetic polymer 
such as HPMC and natural polymer gellan gum.
Results: The granules were evaluated by determining the angle of repose (23.70±0.761 to 29.21±0.127º), bulk density, tapped density, Hausner ratio, 
and Carr’s index. It shows satisfactory results. The tablets were subjected to the measurement of hardness (3.9±0.08 to 4.6±0.04kg/cm2), friability 
(0.22±0.004 to 0.40±0.005%), and in vitro release studied. Release study of pure drug was performed. In the release study, SD of glimepiride tablets 
with gellan gum gives considerably good result compared to HPMC.
Conclusion: From the results, it was shown that dissolution rate of pure glimepiride was very slow. When the glimepiride was prepared in SD form, 
then the dissolution rate was very fast. The tablets of the SD of glimepiride were prepared and release study was shown depending on various 
quantities of HPMC and gellan gum used. Therefore, the long term stability study is required for future development of this formulation.
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INTRODUCTION
Diabetes mellitus (DM) is a one of the major concerns across the globe. 
It is a group of metabolic disorder characterized by abnormal high 
blood glucose level occurred due to low insulin level or defect in insulin 
secretion. DM is differentiated into two major types, i.e., Type I (insulin-
dependent diabetes) and Type II (insulin-independent diabetes). In 
Type I diabetes, destruction of beta cells of pancreatic islets leads to 
the low level of insulin and so the resistance of glucose level in blood 
is decreased. Type II diabetes is a result of the lower response of 
glucoreceptor of beta cells or reduced number of insulin or relative 
deficiency of insulin due to large secretion of hyperglycemia hormones 
(glucagon, etc.) or obesity. For the treatment of DM, many drugs 
are in use, the most effective one is insulin, but its main drawback is 
that it must be given by injection. To overcome these drawbacks, oral 
hypoglycemic drugs came into use [1,2].
Glimepiride is the newest second-generation sulfonylurea and is 
sometimes classified as the third generation sulfonylurea. It is found 
to have significant action in lowering off blood glucose level in 
Type II diabetes. Glimepiride has shown to act for long period than 
glipizide. FDA also approved its use in combination with insulin and 
metformin. Its administration is quite difficult as it is poorly soluble 
in aqueous medium and slow dissolution rate, which leads to poor 
bioavailability [3,4].
Solid dispersion (SD) is one of the techniques to increase the solubility 
and dissolution rate of poorly soluble drugs. This technique is shown 
to have successfully improved the solubility and dissolution rate 
of glimepiride. Therefore, our main objective is to prepare SD of 
glimepiride with urea by fusion method and formulated as tablets along 
with HPMC or gellan gum. Then, the formulated tablets are evaluated by 
various tests to observe its dissolution rate [5,6].
MATERIALS AND METHODS
Materials
Glimepiride and gellan gum are purchased from Yerrow Chem Pvt., Ltd. 
HPMC, magnesium stearate, and talc were purchased from Loba Chemie 
Pvt., Ltd. (Mumbai). Mark Speciality Pvt. Ltd. (Mumbai) supplied 
microcrystalline cellulose (MCC).
Methods
Preparation of SD by fusion method
In fusion method, urea is first melted in water bath with gradual 
increase in temperature until it completely melts. Now, drug is added in 
the melted urea with constant stirring and leaves this mixture to cool at 
room temperature. The ratio of drug and urea taken is 1:1. The mixture 
was dried, crushed, pulverized, and passed through sieve number #60 
and stored in desiccators [7-9].
Preparation of tablets
SD of glimepiride tablets was prepared by wet granulation method 
using single punch tablet compression machine. Glimepiride, HPMC or 
gellan gum, and MCC mixed properly. The binder solution was added 
slowly so that the granules are formed uniformly. After drying, talc and 
magnesium stearate added with granules. The granules are placed in 
a tablet compression machine to obtain number of tablets of uniform 
size and shape [10]. The various compositions of glimepiride SD tablets 
shown on the Table 1.
Characterization of granules flow characteristics
Bulk density
A known quantity (m) of granules was poured into the measuring 
cylinder carefully. The granules were leveled without compacting, if 
necessary and read the unsettled apparent volume (V), to the nearest 
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graduated unit. The bulk density was calculated and expressed in gm 
per ml, by the formula m/V [11].
Tapped density
A known quantity of granules was taken in a measuring cylinder and 
tapped on mechanical tapping apparatus for 5 min. The initial and final 
volumes were noted [11].
Tapped density=Weight of granules/Final volume after tapping
Angle of repose
The frictional forces in a loose powder or granules can be measured by 
the angle of repose. This is the maximum angle possible between the 
surface of a pile of powder or granules and the horizontal plane. This is 
done by funnel method [12]. The value of angle of repose is calculated 
using the following formula:
tan θ=h/r
θ=tan–1 (h/r)
Where, θ=Angle of repose, h =Height of the heap, and r=Radius of the 
heap
Compressibility index and Hausner ratio
The compressibility index and the closely related Hausner ratio have 
become the simple, fast, and popular methods of predicting granules 
flow characteristics. The compressibility index and Hausner ratio were 
determined by measuring both the bulk density and tapped density of 
granules [13].
Compressibility index=(Tapped density−Bulk density)/Tapped 
density×100
Hausner ratio= Tapped density/bulk density
Evaluation of tablets
Hardness test
Hardness of the tablets was measured by Monsanto hardness 
tester [14].
Friability test
Friability of the tablets was measured by Roche friabilator [15].
Dissolution
The dissolution test was performed by USP dissolution test apparatus 
Type II containing 900 ml of 7.8 phosphate buffer for 3 h at 
50 rpm [16,17].
RESULTS AND DISCUSSION
The results of bulk density, tapped density, angle of repose, Hausner 
ratio, and compressibility index are shown in Table 2. The hardness and 
friability of the prepared glimepiride SD tablets are shown in Table 3. 
The granules were evaluated by determining the angle of repose 
(23.70±0.761–29.21±0.127), bulk density (0.32±0.008–0.47±0.018), 
tapped density (0.44±0.006–0.59±0.001), Hausner ratio 
(1.25±0.020–1.42±0.017), and Carr’s index (11.42±0.09–15.80±0.07). 
It showed satisfactory results. The tablets were subjected to 
measurement of hardness (3.9±0.08–4.6±0.04 kg/cm2) and friability 
(0.22±0.004–0.40±0.005 %). It also showed satisfactory results.
The dissolution rate of pure glimepiride was very slow (24.67% 
at 3 h). When the glimepiride was prepared in SD form, then the 
dissolution rate was very fast. The tablets of SD of glimepiride 
Table 2: Precompression evaluation
Formulation code Bulk density (Kg/cm3) Tapped density (Kg/cm3) Carr’s index Hauser’s ratio Angle of Repose (˚)
F1 0.32±0.008 0.44±0.006 11.72±0.06 1.37±0.025 25.62±0.435
F2 0.40±0.012 0.57±0.002 12.80±0.04 1.42±0.017 29.21±0.127
F3 0.32±0.009 0.42±0.007 15.80±0.07 1.31±0.022 26.58±0.402
F4 0.44±0.015 0.56±0.003 11.42±0.09 1.27±0.023 24.94±0.533
F5 0.45±0.016 0.57±0.003 14.05±0.03 1.26±0.018 24.42±0.424
F6 0.47±0.018 0.59±0.001 13.33±0.04 1.25±0.020 23.70±0.761
All values are expressed as Mean±(t×SEM), n=3
Fig. 1: Release profile of glimepiride solid dispersion tablets
Table 1: Composition of glimepiride SD tablets
Ingredients F1 F2 F3 F4 F5 F6
Glimepiride (SD) 100 100 100 100 100 100
HPMC 80 100 120 - - -
Gellan gum - - - 80 100 120
MCC 170 150 130 170 150 130
Magnesium stearate 5 5 5 5 5 5
Talc 5 5 5 5 5 5
SD: Solid dispersion
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were prepared and release study was shown depending on 
various quantities of HPMC and gellan gum used. The release 
studies of formulations (F4, F5, and F6) of glimepiride SD tablets 
using gellan gum were found 87.9315, 81.8762, and 68.8681%, 
respectively, at 3h. Release pattern of tablets using gellan gum is 
very satisfactory. The gellan gum is natural polymer, so it is added 
advantages to prepare tablets using this gum. The results are shown 
in Fig 1. Therefore, the long term stability study is required for future 
development of this formulation.
CONCLUSION
The dissolution rate of pure glimepiride was very slow. When the 
glimepiride was prepared in SD form, then the dissolution rate was 
very fast. The tablets of the SD of glimepiride were prepared and 
release study was shown depending on various quantities of HPMC and 
gellan gum used. The release of glimepiride SD tablets using gellan gum 
was better compare to tablets prepared with HPMC. As the dissolution 
rate of glimepiride SD tablets increased, then bioavailability also 
increased. Therefore, the long term stability study is required for future 
development of this formulation.
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